December 2018

Contents

Editorial

• 12 December 2018: vol 19 no 18: Final issue of 2018

Conference reports

• Glasgow HIV Congress (2018) – second reports

• Hepatitis C is an independent risk factor for preterm delivery in HIV positive women: data from a Warsaw cohort

• Vertical transmission remains very low in UK and Ireland: update from the National Study of HIV in Pregnancy and Childhood 

• 3rd HIV Research for Prevention Conference (R4P2018) – second reports

• 3D printing technology has potential to individualise production of vaginal rings

• 22nd International AIDS Conference (AIDS 2018) – final report

• No significant decrease in raltegravir free fraction during pregnancy

Antiretrovirals

• FDA approves generic TDF/3TC for use in the US

• Doravirine (Pifeltro) and doravirine/TDF/3TC FDC (Delstrigo) approved in Europe

PK and drug interactions

• Updates from Liverpool University drug interactions website

Cure-related research

• New community recommendations for HIV cure studies that include a treatment interruption

Other news

• IAS condemns Tanzania’s anti-gay initiatives

• Essential viewing: Live Growing Up – CHIVA 2018 video…

PDFs

• 12 December 2018: vol 19 no 18